Collplant Historical Balance Sheet

CLGN Stock

USD 2.65 0.06 2.21%

Trend analysis of Collplant Biotechnologies balance sheet accounts such as Total Assets of 18.4 M, Other Current Liabilities of 2 M or Total Current Liabilities of 2.5 M provides information on Collplant Biotechnologies' total assets, liabilities, and equity, which is the actual value of Collplant Biotechnologies to its prevalent stockholders. By breaking down trends over time using Collplant Biotechnologies balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Collplant Biotechnologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Collplant Biotechnologies is a good buy for the upcoming year.

Collplant Biotechnologies Inventory

695,338

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.

About Collplant Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Collplant Biotechnologies at a specified time, usually calculated after every quarter, six months, or one year. Collplant Biotechnologies Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Collplant Biotechnologies and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Collplant currently owns. An asset can also be divided into two categories, current and non-current.

Collplant Biotechnologies Balance Sheet Chart

At this time, Collplant Biotechnologies' Liabilities And Stockholders Equity is very stable compared to the past year. As of the 29th of March 2025, Other Current Assets is likely to grow to about 283.1 K, while Common Stock Shares Outstanding is likely to drop about 6.1 M.

Common Stock Shares Outstanding Total Assets Other Current Liab Total Current Liabilities

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Collplant Biotechnologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Collplant Biotechnologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Collplant Biotechnologies balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Collplant Biotechnologies are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Collplant Biotechnologies' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Collplant Biotechnologies current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.At this time, Collplant Biotechnologies' Liabilities And Stockholders Equity is very stable compared to the past year. As of the 29th of March 2025, Other Current Assets is likely to grow to about 283.1 K, while Common Stock Shares Outstanding is likely to drop about 6.1 M.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	914K	1.6M	1.9M	2.0M
Total Assets	37.8M	34.1M	18.7M	18.4M

Other Current Liab Total Assets

Collplant Biotechnologies balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock	Net Tangible Assets	Property Plant Equipment	Non Current Liabilities Total
Common Stock Shares Outstanding		0.86	0.74	0.86	0.79	0.92	-0.7	-0.87	0.6	0.74	0.93	-0.25	-0.24	0.84	-0.44	0.89	0.62	0.98	0.79	0.85	0.8	-0.78	0.91	0.85	0.87	0.63
Total Assets	0.86		0.44	0.62	0.99	0.76	-0.66	-0.62	0.51	0.79	0.78	-0.05	-0.3	0.89	-0.5	0.68	0.58	0.81	0.58	0.68	0.99	-0.48	0.75	0.78	0.64	0.48
Other Current Liab	0.74	0.44		0.8	0.34	0.79	-0.59	-0.94	0.43	0.42	0.79	-0.52	-0.33	0.62	-0.36	0.93	0.32	0.76	0.74	0.92	0.36	-0.82	0.89	0.74	0.74	0.64
Total Current Liabilities	0.86	0.62	0.8		0.51	0.95	-0.43	-0.83	0.64	0.5	0.94	-0.15	-0.12	0.56	-0.25	0.9	0.46	0.82	0.93	0.76	0.54	-0.96	0.79	0.6	0.91	0.74
Total Stockholder Equity	0.79	0.99	0.34	0.51		0.67	-0.67	-0.53	0.44	0.79	0.69	-0.04	-0.3	0.89	-0.54	0.58	0.53	0.74	0.45	0.62	1.0	-0.36	0.68	0.76	0.55	0.35
Property Plant And Equipment Net	0.92	0.76	0.79	0.95	0.67		-0.56	-0.86	0.58	0.63	1.0	-0.22	-0.25	0.7	-0.47	0.91	0.48	0.9	0.86	0.82	0.68	-0.92	0.85	0.72	0.92	0.68
Net Debt	-0.7	-0.66	-0.59	-0.43	-0.67	-0.56		0.74	-0.36	-0.89	-0.57	0.53	0.53	-0.8	0.66	-0.63	-0.4	-0.75	-0.31	-0.72	-0.65	0.31	-0.79	-0.88	-0.47	-0.21
Retained Earnings	-0.87	-0.62	-0.94	-0.83	-0.53	-0.86	0.74		-0.58	-0.61	-0.85	0.44	0.3	-0.77	0.45	-0.97	-0.53	-0.9	-0.78	-0.94	-0.55	0.8	-0.98	-0.88	-0.82	-0.67
Accounts Payable	0.6	0.51	0.43	0.64	0.44	0.58	-0.36	-0.58		0.41	0.59	0.05	0.35	0.47	0.01	0.56	0.45	0.58	0.61	0.5	0.47	-0.49	0.57	0.52	0.75	0.45
Cash	0.74	0.79	0.42	0.5	0.79	0.63	-0.89	-0.61	0.41		0.65	-0.39	-0.49	0.72	-0.54	0.57	0.49	0.75	0.42	0.58	0.78	-0.35	0.68	0.74	0.5	0.3
Non Current Assets Total	0.93	0.78	0.79	0.94	0.69	1.0	-0.57	-0.85	0.59	0.65		-0.2	-0.26	0.71	-0.48	0.91	0.49	0.91	0.85	0.83	0.7	-0.91	0.86	0.73	0.92	0.68
Non Currrent Assets Other	-0.25	-0.05	-0.52	-0.15	-0.04	-0.22	0.53	0.44	0.05	-0.39	-0.2		0.36	-0.22	0.24	-0.28	0.12	-0.33	-0.08	-0.5	-0.02	0.2	-0.38	-0.4	-0.17	-0.05
Other Assets	-0.24	-0.3	-0.33	-0.12	-0.3	-0.25	0.53	0.3	0.35	-0.49	-0.26	0.36		-0.38	0.46	-0.3	0.02	-0.31	-0.13	-0.32	-0.29	0.12	-0.34	-0.32	0.08	-0.19
Cash And Short Term Investments	0.84	0.89	0.62	0.56	0.89	0.7	-0.8	-0.77	0.47	0.72	0.71	-0.22	-0.38		-0.62	0.76	0.54	0.84	0.51	0.85	0.89	-0.44	0.88	0.95	0.61	0.44
Net Receivables	-0.44	-0.5	-0.36	-0.25	-0.54	-0.47	0.66	0.45	0.01	-0.54	-0.48	0.24	0.46	-0.62		-0.41	-0.08	-0.48	-0.05	-0.53	-0.49	0.25	-0.54	-0.64	-0.37	0.05
Common Stock Total Equity	0.89	0.68	0.93	0.9	0.58	0.91	-0.63	-0.97	0.56	0.57	0.91	-0.28	-0.3	0.76	-0.41		0.56	0.88	0.86	0.92	0.61	-0.88	0.96	0.82	0.84	0.76
Other Current Assets	0.62	0.58	0.32	0.46	0.53	0.48	-0.4	-0.53	0.45	0.49	0.49	0.12	0.02	0.54	-0.08	0.56		0.58	0.61	0.39	0.57	-0.38	0.56	0.54	0.46	0.67
Other Stockholder Equity	0.98	0.81	0.76	0.82	0.74	0.9	-0.75	-0.9	0.58	0.75	0.91	-0.33	-0.31	0.84	-0.48	0.88	0.58		0.75	0.86	0.75	-0.75	0.91	0.87	0.86	0.6
Total Liab	0.79	0.58	0.74	0.93	0.45	0.86	-0.31	-0.78	0.61	0.42	0.85	-0.08	-0.13	0.51	-0.05	0.86	0.61	0.75		0.68	0.5	-0.9	0.73	0.52	0.79	0.93
Property Plant And Equipment Gross	0.85	0.68	0.92	0.76	0.62	0.82	-0.72	-0.94	0.5	0.58	0.83	-0.5	-0.32	0.85	-0.53	0.92	0.39	0.86	0.68		0.63	-0.73	0.96	0.91	0.78	0.58
Total Current Assets	0.8	0.99	0.36	0.54	1.0	0.68	-0.65	-0.55	0.47	0.78	0.7	-0.02	-0.29	0.89	-0.49	0.61	0.57	0.75	0.5	0.63		-0.38	0.69	0.76	0.56	0.42
Intangible Assets	-0.78	-0.48	-0.82	-0.96	-0.36	-0.92	0.31	0.8	-0.49	-0.35	-0.91	0.2	0.12	-0.44	0.25	-0.88	-0.38	-0.75	-0.9	-0.73	-0.38		-0.74	-0.52	-0.87	-0.74
Common Stock	0.91	0.75	0.89	0.79	0.68	0.85	-0.79	-0.98	0.57	0.68	0.86	-0.38	-0.34	0.88	-0.54	0.96	0.56	0.91	0.73	0.96	0.69	-0.74		0.95	0.8	0.63
Net Tangible Assets	0.85	0.78	0.74	0.6	0.76	0.72	-0.88	-0.88	0.52	0.74	0.73	-0.4	-0.32	0.95	-0.64	0.82	0.54	0.87	0.52	0.91	0.76	-0.52	0.95		0.69	0.43
Property Plant Equipment	0.87	0.64	0.74	0.91	0.55	0.92	-0.47	-0.82	0.75	0.5	0.92	-0.17	0.08	0.61	-0.37	0.84	0.46	0.86	0.79	0.78	0.56	-0.87	0.8	0.69		0.56
Non Current Liabilities Total	0.63	0.48	0.64	0.74	0.35	0.68	-0.21	-0.67	0.45	0.3	0.68	-0.05	-0.19	0.44	0.05	0.76	0.67	0.6	0.93	0.58	0.42	-0.74	0.63	0.43	0.56

Click cells to compare fundamentals

Collplant Biotechnologies Account Relationship Matchups

Collplant Biotechnologies balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	6.9M	12.0M	11.0M	11.4M	11.5M	6.1M
Total Assets	10.8M	51.2M	37.8M	34.1M	18.7M	18.4M
Other Current Liab	1.5M	910K	914K	1.6M	1.9M	2.0M
Total Current Liabilities	3.4M	3.0M	3.1M	3.3M	3.0M	2.5M
Total Stockholder Equity	4.5M	45.1M	32.3M	28.3M	13.5M	13.8M
Property Plant And Equipment Net	4.9M	5.7M	5.7M	5.9M	5.3M	3.5M
Net Debt	55K	(9.5M)	(26.7M)	(23.5M)	(21.2M)	(20.1M)
Retained Earnings	(73.0M)	(72.8M)	(89.7M)	(96.7M)	(113.4M)	(107.7M)
Accounts Payable	798K	1.0M	1.1M	980K	870K	921.3K
Cash	3.3M	13.1M	29.7M	26.7M	11.9M	10.2M
Non Current Assets Total	5.2M	6.1M	6.1M	6.1M	5.5M	4.0M
Non Currrent Assets Other	181K	213K	188K	57K	118K	129.5K
Other Assets	168K	181K	213K	1.0	0.9	0.86
Cash And Short Term Investments	3.3M	43.3M	29.7M	26.7M	30.7M	32.2M
Net Receivables	830K	270K	9K	393K	150K	142.5K
Liabilities And Stockholders Equity	10.8M	51.2M	37.8M	34.1M	39.2M	41.2M
Other Current Assets	251K	437K	566K	241K	277.2K	283.1K
Other Stockholder Equity	75.5M	114.2M	118.1M	121.1M	139.2M	76.5M
Total Liab	6.4M	6.1M	5.5M	5.8M	5.2M	4.6M
Property Plant And Equipment Gross	4.9M	9.7M	5.7M	11.9M	12.3M	12.9M
Total Current Assets	5.7M	45.1M	31.7M	28.0M	13.2M	14.4M
Common Stock	2.9M	4.7M	4.9M	5.0M	5.7M	6.0M
Net Tangible Assets	5.4M	4.1M	4.4M	44.9M	51.6M	54.2M
Inventory	1.3M	1.1M	1.4M	714K	440K	695.3K
Short Term Debt	880K	1.0M	1.1M	624K	717.6K	451.2K
Property Plant Equipment	1.4M	5.5M	4.9M	5.7M	6.5M	3.5M
Non Current Liabilities Total	3.0M	3.1M	2.4M	2.5M	2.3M	2.8M
Short Long Term Debt Total	3.4M	3.6M	2.9M	3.2M	3.6M	3.2M
Net Invested Capital	4.5M	45.1M	32.3M	28.3M	13.5M	19.1M
Net Working Capital	2.3M	42.1M	28.6M	24.8M	10.2M	16.4M
Capital Stock	2.9M	4.7M	4.9M	5.0M	5.0M	4.1M

Pair Trading with Collplant Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Collplant Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Collplant Stock

0.67

CDIOW

Cardio Diagnostics

Pair Corr

Moving against Collplant Stock

0.71	LUCD	Lucid Diagnostics	Pair Corr
0.65	WM	Waste Management	Pair Corr
0.6	PG	Procter Gamble Sell-off Trend	Pair Corr
0.48	GE	GE Aerospace	Pair Corr

The ability to find closely correlated positions to Collplant Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Collplant Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Collplant Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Collplant Biotechnologies to buy it.

The correlation of Collplant Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collplant Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collplant Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Collplant Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Collplant Biotechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Collplant Biotechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Collplant Biotechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Collplant Biotechnologies Stock:

How To Invest In Collplant

Details

Is Collplant Stock a good investment?

Details

What is Collplant Biotechnologies' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.

You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.45)

Revenue Per Share

0.057

Quarterly Revenue Growth

(0.91)

Return On Assets

(0.38)

Return On Equity

(0.71)

The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Collplant Historical Balance Sheet

Collplant Biotechnologies Inventory

695,338

About Collplant Balance Sheet Analysis

Collplant Biotechnologies Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Total Current Liabilities

Collplant Biotechnologies balance sheet Correlations

Collplant Biotechnologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Collplant Biotechnologies balance sheet Accounts

Pair Trading with Collplant Biotechnologies

Moving together with Collplant Stock

Moving against Collplant Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Other Stockholder Equity	+ 0.98	Common Stock Shares Outstanding
Common Stock	+ 0.96	Common Stock Total Equity

Common Stock	- 0.98	Retained Earnings
Common Stock Total Equity	- 0.97	Retained Earnings
Intangible Assets	- 0.96	Total Current Liabilities
Property Plant And Equipment Gross	- 0.94	Retained Earnings
Retained Earnings	- 0.94	Other Current Liab
Intangible Assets	- 0.92	Property Plant And Equipment Net